VibroSense Dynamics

QST Technologies has also received a first order for delivery to the Duchess of Kent Children's Hospital at Sandy Bay which is a new customer in Hong Kong. The agreement with QST is a non-exclusive distributor agreement that applies to Singapore and Hong Kong but not to China “Mainland” where UMCARE has an exclusive distributor rights which is valid for three years from the date of receipt of regulatory approval from the Chinese authority NMPA.

“It is gratifying to expand our presence in Asia and now we have the opportunity to make VibroSense Meter® II available to clinics in Singapore and Hong Kong. We have already received our first order from a hospital in Hong Kong via QST Technologies and we look forward to a good collaboration,” says Tarik Cengiz, CEO of VibroSense Dynamics AB.

About Technologies
QST was established in 2005 to provide products and solutions to the healthcare industry. Its customers include medical, dental and veterinary practices. Their expertise lies in providing innovative solutions for the complex and demanding healthcare industry, offering specialized and integrated solutions based on new technological advances to meet the ever-increasing healthcare needs.

With a highly competent and dedicated team of professionals, QST is committed to helping their customers and partners achieve beyond their goals. The business growth has been built upon trust and reliability, with offices situated in Singapore, Malaysia and Hong Kong and a growing sales network spanning Asia.

Contact
Tarik Cengiz , CEO VibroSense Dynamics AB
Tel: +46 40 88 026
Email: info@vibrosense.com
www.vibrosense.se
"The new Gold Standard for reliable
detection of nerve damage"

About VibroSense Dynamics AB ( publ )
VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.

Our vision is for the company's products to be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.